Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injury-Reference-Cited by-同舟云学术

Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injury

Published:2023-02 Issue:2 Volume:78 Page:293-300
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Chalasani Naga^ORCID,Li Yi-Ju^ORCID,Dellinger Andrew^ORCID,Navarro Victor,Bonkovsky Herbert,Fontana Robert J.,Gu Jiezhun,Barnhart Huiman,Phillips Elizabeth,Lammert Craig^ORCID,Schwantes-An Tae-Hwi^ORCID,Nicoletti Paola,Kleiner David E.^ORCID,Hoofnagle Jay H.

Publisher

Elsevier BV

Subject

Hepatology

Reference30 articles.

1. LiverTox: clinical and research information on drug-induced liver injury,2012

2. Kane SP. Nitrofurantoin, ClinCalc DrugStats Database, Version 2021.10. ClinCalc: https://clincalc.com/DrugStats/Drugs/Nitrofurantoin. Updated September 15, 2021. Accessed December 27, 2021.

3. Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study;Chalasani;Gastroenterology,2015

4. Drug induced acute liver failure: results of a U.S. multicenter prospective study;Reuben;Hepatology,2010

5. Trends in liver transplant waitlisting and outcomes for drug-induced liver injury in the United States;Ghabril;Liver Transplant,2022

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary, Hepatic, and Renal Fibrosis due to Nitrofurantoin in Rat Pups;Cyprus Journal of Medical Sciences;2024-08-29

2. Glucocorticoid efficacy and treatment strategies for drug-induced liver injury: a literature review;Molecular Biology Reports;2024-07-31

3. Clinical characteristics and HLA associations of azithromycin‐induced liver injury;Alimentary Pharmacology & Therapeutics;2024-07-10

4. Immunopathogenesis of Primary Biliary Cholangitis, Primary Sclerosing Cholangitis and Autoimmune Hepatitis: Themes and Concepts;Gastroenterology;2024-06

5. Hepatotoxicity of Antibiotics and Antifungals and Their Safe Use in Hepatic Impairment;Seminars in Liver Disease;2024-05